Clinical Trials Logo

Brain Injury clinical trials

View clinical trials related to Brain Injury.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03157453 Terminated - Brain Injury Clinical Trials

Comparison of Two Initial Evaluation Scales of the Severity of Brain Injury Adults Patients on the Neurological Outcome at 6 Months

CASSANDRA
Start date: August 7, 2017
Phase:
Study type: Observational

Prospective cohort study. Any patient with potential cerebral injured (medical or traumatic) will be included in the study, regardless of its severity, history, the presence of anticoagulant or antiagrégant. The collection should be done as soon as possible, in the reception of vital emergencies or in the urgencies. The collection consists of the realization of a Glasgow score and a scale of Kremlin-Bicêtre for all patients by completing a standardized collection sheet. The collection of GCS and Kremlin-Bicêtre must be did at the same time. The collection sheet is filled by medical personnel trained. The future of the patient is informed at 6 months using the Glasgow Outcome Scale- Extended, which will be made during a following consultation or by phone. Additional data will be collected on the folder (ventilation time, days of hospitalization, mortality).

NCT ID: NCT02215148 Terminated - Brain Injury Clinical Trials

Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients

Start date: November 2014
Phase: N/A
Study type: Observational

To assess the pharmacokinetic profile of tolvaptan in critically ill acute brain injury patients and to secondarily evaluate the clinical response and safety of tolvaptan in acute brain injured patients

NCT ID: NCT01374633 Terminated - Brain Injury Clinical Trials

Sevoflurane Sedation on Intra Cranial Pressure in Traumatic Brain Injury Patients

SEPIA
Start date: December 2011
Phase: Phase 2
Study type: Interventional

Main purpose of the study is to evaluate the effect of sevoflurane on intra cranial pressure (ICP) after traumatic brain injury. Patients admitted for traumatic brain injury equipped with ICP measurement will be sedated with sevoflurane via the Anaconda device during 12 hours. Sedation will be controlled with BIS.

NCT ID: NCT01112969 Terminated - Brain Injury Clinical Trials

OSCAR - An Internet-based Supportive Coaching for Informal Caregivers of Adult Individuals With an Acquired Brain Injury

Start date: January 2010
Phase: Phase 2
Study type: Interventional

This is an intervention study for informal caregivers of adult patients with an acquired brain injury (stroke, traumatic brain injury or cerebral haemorrhage). It will determine whether an internet-based supportive coaching offers benefits to the caregivers in their own process of coping in the aftermath of a brain injury of a close relative. We expect the internet-based supportive coaching to be more effective in the treatment of emotional distress reactions and caregiver burden than the treatment as usual.

NCT ID: NCT00842413 Terminated - Brain Injury Clinical Trials

Investigating the Role of the Premotor Cortex in Higher Cognitive Functions

Start date: May 2007
Phase: N/A
Study type: Observational

This project aims at understanding better the role of the frontal lobe of the brain in our capacity to perceive visual information consciously, and also, in our capacity to perceive others' actions. It includes a test where we ask subjects to detect visual information in front of a computer screen, and another test where we ask them to imitate finger movements.

NCT ID: NCT00746291 Terminated - Cerebral Palsy Clinical Trials

Heart Rate Variability (HRV) Among Children With Brain Damage

Start date: June 2008
Phase: N/A
Study type: Interventional

to investigate the function of the autonomic nervous system in children with with post traumatic brain injury and children with cerebral palsy through an analysis of heart rate variability (HRV) occurring with walking performance.

NCT ID: NCT00589953 Terminated - Brain Injury Clinical Trials

High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study

Start date: July 2007
Phase: Phase 2
Study type: Interventional

The highest risk for perinatal brain injury occurs among extremely premature infants who weigh less than 1250 grams at birth. Such perinatal brain injury is currently irreversible, associated with neurodevelopmental disability, and without adequate treatment modalities. Research in recent years suggest in both animal and human studies that erythropoietin (Epo) may have significant neuroprotective effects. Given the historical safe medical profile of Epo when used for anemia of prematurity but the likely need for a greater dosage regimen for activation of neuroprotective pathways against neonatal brain injury, we therefore propose this phase II study of high-dose Epo in very low birth weight infants for the prevention and/or attenuation of prematurity-related cerebral hemorrhagic-ischemic injury.

NCT ID: NCT00538369 Terminated - Brain Injury Clinical Trials

Combining Observational and Physiologic Sedation Assessment Tools

COST
Start date: November 2006
Phase: Phase 4
Study type: Interventional

When a physiologic tool to measure the patient's hypnotic state is added to current practice tools is there a decrease in the amount of drug the patient receives.